OpenEvidence

OpenEvidence @OpenEvidence

Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.

OpenEvidence @OpenEvidence

Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.

OpenEvidence @OpenEvidence

Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence. Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States. As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.

Financial Times @FT

The $15bn ‘viral’ AI start-up changing how American doctors treat patients

NEJM @NEJM

Join @NEJM_AI for a free virtual event to explore how AI is reshaping guideline development and clinical decision-making. Hear from leading experts as they discuss how to harness the strengths of large language models while preserving clinician autonomy, minimizing bias, and ensuring that evidence—not algorithms alone—continues to guide patient care. View the speaker lineup and save your seat:

The Faulkner Focus @FaulknerFocus

@NIHDirector_Jay discusses how AI tools like OpenEvidence can help doctors connect the latest medical research to patient symptoms and treatment options.

Berci Meskó, MD, PhD @Berci

OpenEvidence, as a physician-facing LLM, is being used by more healthcare professionals month by month. Now, a study analyzes how almost a million US clinicians use it while submitting 271 million AI-enabled clinical queries! "Early-career physicians (use ratio, 2.54) and those in oncology and hematology (2.00), internal medicine (1.88), and family medicine (1.80) submitted a higher-than-average share of queries; treatment and management accounted for 33.1% of physician queries and diagnosis for 13.9%." I really liked their concluding remark: "For much of modern medicine, clinicians have been expected to internalize a body of knowledge through training and maintain it through continuing education. Study findings suggest a growing share of knowledge access is shifting from recall to retrieval." We cannot expect physicians to know everything, but we can expect them to know where to find the information they need. The study:

JAMA @JAMA_current

Among US #clinicians, use of an #AI-enabled clinical information platform increased substantially over 2.5 years, with sustained use across #physician and nonphysician groups. Queries most often focused on #treatment and #management rather than #diagnosis, indicating that these tools are being used primarily to support #clinical decision-making at the point of care.